openPR Logo
Press release

Acute Kidney Injury Therapeutics Pipeline Analysis Report 2018

07-02-2018 07:38 AM CET | Health & Medicine

Press release from: P&S Market Research-Pharmaceuticals

Acute Kidney Injury Therapeutics Pipeline Analysis Report 2018

Acute kidney injury (AKI) or acute kidney failure is a condition characterized by minor or complete loss of kidney function due to a sudden injury to kidneys. AKI is different from chronic kidney disease, wherein the kidney function is lost over a period of time. The disease generally occurs as a complication of another serious disease and is more common in the geriatric population that suffers from various other diseases. The study analyzed that AKI therapeutics pipeline comprises approximately 40 drug candidates in different stages of development.

Access Report Summary with Detailed TOC@ https://www.psmarketresearch.com/market-analysis/acute-kidney-injury-therapeutic-pipeline-analysis

Various health organizations such as National Institute of Diabetes and Digestive and Kidney Diseases and Small Business Innovation Research (SBIR) program of the U.S. Small Business Administration (SBA) are strengthening the growth of AKI therapeutics pipeline. For instance, TheraSource LLC received a funding of $335,318 from SBIR for its research project aimed at demonstrating the feasibility of developing recombinant human milk fat globule epidermal growth factor rhMFG E, as a novel and effective therapeutic for treating patients suffering with AKI, associated with ischemia due to low renal perfusion.

Request to Get the Sample Report@ https://www.psmarketresearch.com/market-analysis/acute-kidney-injury-therapeutic-pipeline-analysis/report-sample

There has been an increase in the number of patents approved for the development of drug candidates for the treatment of AKI. For instance, in October 2016, the USPTO issued U.S. Patent 9,464,114 to Arch BioPartners, entitled, “Peptides that Block Leukocyte Recruitment and Methods of Use”. This was the first patent issued protecting the composition and method of use for Metablok.

Make Enquiry Before Buying the Report@ https://www.psmarketresearch.com/send-enquiry?enquiry-url=acute-kidney-injury-therapeutic-pipeline-analysis

Most of the companies are developing innovative technologies for the synthesis or production of drug candidates for the treatment of AKI. For instance, Quark Pharmaceuticals Inc. is using an innovative technology platform for generation of chemically modified siRNA compounds and their delivery to the desired organs. These are particularly well-suited to exploit the potential of siRNA for therapeutic applications. Also, Silver Creek Pharmaceuticals Inc. is using smart growth factor technology platform for the development of growth factors that play an important role in development, maintenance of tissue homeostasis, and pathology of many disease states.

Some of the key players involved in the development of AKI therapeutics include Alloksys Life Sciences B.V., Stealth BioTherapeutics Inc., and Angion Biomedica Corp.

About P&S Market Research
P&S Market Research is a global market research and consulting company. We provide market research reports, industry reports, business intelligence and research-based consulting services across a range of industries.
With the help of our professional corporate relations with various companies, our market research offers the most accurate market forecasting. Our analysts and consultants interact with leading companies of the concerned domain to substantiate every single data presented in our publication. Our research assists our client in identifying new and different windows of opportunity and frame informed and customized strategies for expansion in different regions.

Contact:
P&S Market Research
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Acute Kidney Injury Therapeutics Pipeline Analysis Report 2018 here

News-ID: 1104821 • Views: 295

More Releases for AKI

Acute Kidney Injury (AKI) Market Pipeline Insight- (2025) High Growth Opportunit …
Acute Kidney Injury (AKI) Pipeline Insight, 2020" Report gives comprehensive overview Of Present Clinical Development Scenario And Growth Prospects Across The Acute Kidney Injury (AKI) Market. A Detailed Picture Of The Acute Kidney Injury (AKI) Pipeline Landscape Is Provided, Which Includes The Disease Overview And Acute Kidney Injury (AKI) Treatment Guidelines. A Better Understanding of Disease Pathogenesis Contributing To The Development Of Novel Therapeutics For Acute Kidney Injury (AKI). Get
Home Retailing in Portugal Market Show at 2.3% CAGR to 2022 | IKEA, Leroy Merlin …
Home Retailing in Portugal Market Shares Summary and Forecasts to 2022 "Home Retailing in Portugal, Market Shares, Summary and Forecasts to 2022", provides data for historic and forecast retail sales, and also includes information on the business environment and country risk related to Portugal retail environment. In addition, it analyzes the key consumer trends influencing Portugal home industry. In 2017, home sector sales in Portugal stood at 4.6 billion and are projected
Acute Kidney Injury Therapeutics 2018 - Key Players Analysis Angion Biomedica Co …
Acute kidney injury (AKI) or acute kidney failure is a condition characterized by minor or complete loss of kidney function due to a sudden injury to kidneys. AKI is different from chronic kidney disease, wherein the kidney function is lost over a period of time. The disease generally occurs as a complication of another serious disease and is more common in the geriatric population that suffers from various other diseases.
Acute Kidney Injury Therapeutics Analysis by Top key Players - Stealth BioTherap …
Acute kidney injury (AKI) or acute kidney failure is a condition characterized by minor or complete loss of kidney function due to a sudden injury to kidneys. AKI is different from chronic kidney disease, wherein the kidney function is lost over a period of time. The disease generally occurs as a complication of another serious disease and is more common in the geriatric population that suffers from various other diseases.
3rd Annual Kidney Congress
On behalf of the Conference Series LLC Ltd and the Organizing committee of Kidney 2018, we are pleased to welcome you to participate in the 3rd Annual Kidney Congress. The conference will be held from October 19 - 20, 2018 in New York, USA Major scientific sessions: Kidney Fluid, Electrolytes, Acid-Base Disorders Acute Kidney Injury (AKI) CKD -Mineral and Bone Disorders Chronic Kidney Disease (CKD) Kidney and Bladder stones Dialysis and Renal Care Urology/Urinary Tract Infections Kidney Transplantation Geriatric-Genetic Kidney
Market Research on Continuous Renal Replacement Therapy Market 2016 and Analysis …
Continuous Renal Replacement therapy (CRRT) is a process of extracorporeal blood purification which is intended to substitute for impaired renal function for extended period of time. Continuous Renal Replacement therapy intends at application over 24 hours a day. It is a mode of renal replacement therapy for hemodynamically unstable, fluid over loaded and catabolic septic patients. The major application of CRRT is management of acute renal failure especially in critical